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Abstract The Myt1 family of transcription factors
is unique among the many classes of zinc ﬁnger
proteins in how the zinc-stabilized ﬁngers contact the
DNA helix. To examine the function of Myt1 in the
developing nervous system, we generated mice in
which Myt1 expression was replaced by an enhanced
Green Fluorescent Protein fused to a Codon-
improved Cre recombinase as a protein reporter.
Myt1 knock-in mice die at birth, apparently due to
improper innervation of their lungs. Elimination of
Myt1 did not signiﬁcantly affect the number or
distribution of neural precursor cells that normally
express Myt1 in the embryonic spinal cord. Nor was
the general pattern of differentiated neurons altered in
the embryonic spinal cord. The Myt1 knock-in mice
should provide an important tool for identifying the
in vivo targets of Myt1 action and unraveling the role
of this structurally distinct zinc ﬁnger protein in
neural development.
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Introduction
During development, oligodendrocyte precursor cells
arise in multiple locations and differentiate into the
myelinating cells of the central nervous system.
Much progress has been made in the identiﬁcation of
individual transcription factors required for orches-
trating the multiple waves of oligodendrocyte devel-
opment. (Kessaris et al. 2006; Nicolay et al. 2007;
Wegner 2008). The myelin transcription factor 1
(Myt1) family represents zinc ﬁnger proteins of a
structurally novel CCHC class that were originally
cloned by their binding to the most abundantly
expressed myelin gene in oligodendrocytes: proteoli-
pid protein (Plp1; Kim and Hudson 1992). Myt1 zinc
ﬁngers recognize DNA in a distinct manner, with a
whole zinc ﬁnger sitting snugly in the major groove
of double-stranded DNA (Gamsjaeger et al. 2008).
This manner of interaction contrasts with the classical
GATA-type and steroid hormone zinc ﬁnger proteins,
which all utilize an a-helix to position DNA-
contacting residues in the major groove. Myt1
physically associates with the Sin3B protein, a
corepressor that modiﬁes chromatin structure by
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et al. 2005). Of note, oligodendrocytes contain
multiple forms of Sin3B, both a long form that
includes a HDAC binding site and short forms that
lack a HDAC binding site. Myt1 binding to target
genes can recruit HDAC via Sin3B, with an accom-
panying localized hypo-acetylation of core histones
and resultant transcriptional repression. But in the
face of sufﬁcient amounts of Sin3B short forms, the
Sin3B-Myt1 complexes bound to target genes may
preclude HDAC binding, leading to a state of tran-
scriptional activation. Within the nucleus, Myt1 is
locatedindomainsthataredistinctfromthenucleolus,
coiled bodies, and other nuclear subdomains
(Armstrong et al. 1995). The discrete punctate pattern
ofMyt1immunostainingcoincidedwiththetargetPLP
gene,whichwasassociatedwiththenuclearperiphery,
in half of the cells observed in both progenitors and
differentiated oligodendrocytes (Nielsen et al. 2002).
Mature oligodendrocytes do not express appreciable
amounts of Myt1 and the subcellular distribution of
Myt1 shifts shortly before cells stop expressing Myt1;
consequently the Myt1 protein in mature oligodendro-
cytes is transiently detected in the cytoplasmic com-
partment (Armstrong et al. 1995).
Myt1 modulates the proliferation and differentia-
tion of oligodendrocyte lineage cells in rodents
(Nielsen et al. 2004), as observed following the
introduction of a dominant negative construct con-
taining the four zinc-ﬁnger binding domain of Myt1
into oligodendrocyte primary cultures. Expression of
the dominant negative construct inhibited the prolif-
eration of progenitors as well as their differentiation
into oligodendrocytes, as assessed by bromodeoxy-
uridine incorporation, morphology, migratory char-
acteristics, and myelin gene expression. Myt1 alters
neuronal differentiation in Xenopus (Bellefroid et al.
1996), and together with the basic-helix-loop-helix
protein Neurogenin 3 forms a ‘‘feed-forward’’ expres-
sion loop to promote endocrine islet cell differenti-
ation (Ahnfelt-Ronne et al. 2007; Wang et al. 2008).
Selective knock-out of Myt1 in the pancreas com-
promises islet cell differentiation; of note is the
induction of the paralogs Myt1l and Myt3 in these
animals (Wang et al. 2007). In the nervous system,
Myt1 is expressed in neuroepithelial germinal zones
in rodent embryos (Kim et al. 1997) and continues to
be expressed in germinal zones of adults (Armstrong
et al. 1995). Myt1 cannot be detected in cells
immunostained with TuJ1, which recognizes neurons
undergoing terminal mitosis and accumulates with
further differentiation (Kim et al. 1997). Myt1is
upregulated in gliomas (Armstrong et al. 1997)a s
well as following injury: spinal cord contusion
(Wrathall et al. 1998), murine hepatitis virus—
induced demyelination (Vana et al. 2007) and in
multiple sclerosis lesions (Vana et al. 2007).
An important tool for establishing the in vivo role
of transcription factors whose expression patterns
implicate them in oligodendrocyte development is
loss-of-function transgenic mice. Loss of Myt1 is
hypothesized to affect not only the commitment to
the oligodendrocyte lineage but also the subsequent
differentiation of oligodendrocyte progenitors and the
normal myelinating functions of mature oligodendro-
cytes. As suggested by in vitro overexpression
studies, the Myt1
-/- may have reduced proliferative
capacity as well as altered differentiation abilities
(Nielsen et al. 2004). The Myt1 null mice may also be
expected to suffer from neuronal dysfunction as
suggested from the detection of Myt1 in neural
precursors and selected populations of mature neu-
rons, including motor neurons (Armstrong et al.
1995). In this paper we describe the construction and
initial characterization of Myt1 knock-in mice.
Materials and methods
Construction of the Myt1 targeting vector
The murine myelin transcription factor 1 (Myt1) gene
is MGI:1100535 located on Chr2:181498037-
181562502 bp. Synonyms include: mKIAA0835,
NZF-2a, NZF-2b, Nzf2, Nztf2. A building vector
containing FLP recombinase target binding sites (frt)
ﬂanking a neomycin gene as well as a Cre recom-
binase target binding sites (loxP; pOSfrtLoxP) was
supplied by Dr. Randy Thresher, University of North
Carolina. The following cassettes were subcloned
into this building vector:
1. the 4.9 kb Myt1 50 region of homology, which
corresponds to the portion of intron 1 that ends at
exon 2. This segment was cloned from 129/SvEv
mouse genomic DNA using the forward primer
50TATATATAGCGGCCGCTTACCAGGTAGC
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123CTAATTGG30 and the reverse primer 50GTTA
ATCGGCCGTTCTGAGCTCACCTGCAAAG30.
2. the eGFP gene subcloned from peGFP-C2
(Clontech; Mountain View, CA) using HindIII
and KpnI.
3. the iCre recombinase subcloned from pBlue.iCre
((Shimshek et al. 2002); gift of R. Sprengel)
using HindIII and KpnI. The iCre was ﬁrst
inserted upstream of the SV40 polyadenylation
site in peGFP-C2 and in frame with GFP in order
to create an eGFP-iCre fusion protein. The
coding region of the fusion protein is directly
followed by the polyadenylation site.
4. the 1.4 kb Myt1 30 region of homology, which
corresponds to intron 2 and exon 3. This segment
was cloned from 129/SvEv mouse genomic DNA
using the forward primer 50GCATCGATTCAGT
GCCAATGCAGTCTGGCC30 and the reverse
primer 50ATGCTAGCTGGGAGTTTTGGGTC
ATTGTGG30.
To ensure initiation of translation with the eGFP-
iCre fusion protein, the Myt1 initiation codon located
at the beginning of exon 2 was changed to a GTG.
The ﬁnal 14.548 kb plasmid was sequenced in toto,
which also conﬁrmed that premature initiation of
translation would not occur upstream of eGFP.
The NIH Institutional Biosafety Committee
approved the Recombinant DNA Registration Docu-
ment RD-95-I-06 for the use of this construct in mice.
Derivation and maintenance of transgenic mice
Electroporation of 129/SvEv embryonic stem cells
with the Myt1 targeting construct was carried out by
Dr.RandyThresherattheUniversityofNorthCarolina
AnimalModelsCoreFacility.Cloneswerescreenedby
PCR using the forward primer: 50CACACGC
GTCACCTTAATATGCGAAG30 and the reverse
primer: 50CAGCAAGCCCTTTGTAAGTCACAGT
C30 in order to amplify a 3.4 Kb band in transgenic
animals.
We carried out Southern analysis to identify the
correctly targeted ES cells, which were subsequently
implanted at UNC. Four founders were then trans-
ferred to NIH and two lines (Myt1 A2A2 and Myt1
C6H5) were selected for detailed analysis. To remove
the neomycin cassette, mice were bred for 5 gener-
ations with B6;SJL-Tg(ACTFLPe)9205Dym/J mice
(Jackson Laboratories, Bar Harbor, Maine). This
transgenic strain expresses a variant of the Saccha-
romyces cerevisiae FLP1 recombinase gene under the
direction of the human ACTB promoter. The FLP1
recombinase excises the DNA sequence ﬂanked by frt
sites.
Southern and PCR analysis was carried out to assess
whether recombination had occurred correctly at the
Myt1 locus and to document the removal of the
neomycin cassette. For the PCR analysis of resulting
mice, the forward primer 50ATACGAAGTTATTC
GAAGTTCCTATTCTCTAGAAAG30 andreversepri-
mer 50ACCCTTAAATACTGCATCAAGGAACAA
TCGAGGAGC30 detected a 1,435 bp band in mice
containingtheneomycinsequenceanda230 bpbandin
mice lacking the neomycin sequence.
Neo- animals were back-crossed for at least 10
generations against C57BL/6 mice. Each generation
was genotyped by PCR, and periodically conﬁrmed
with Southern Blot experiments. The ﬁnal back-
crosses are maintained as two heterozygous lines
lacking neomycin (Myt1?/Myt1-, neo-/neo-). All
the breedings are documented in a computerized
Filemaker-based animal breeding database. Animals
were handled according to IACUC guidelines under
animal protocol #1155-04. These ‘‘Myt1GFPicre-
KnockIn’’ mice are freely available through the
Mutant Mouse Regional Resource Centers
(MMRRC) under the MMRRC ID#:031888.
Southern/Northern analysis and routine
genotyping
Southern analysis was conducted on DNA puriﬁed
from liver or whole embryos using a standard phenol
extraction followed in some cases by a DNeasy
treatment (Qiagen; Valencia, CA). Following restric-
tion enzyme treatment, DNA was electrophoresed on
0.7% agarose gels. The marker lane consisted of the
1 kb DNA ladder Plus (Fermentas; Burlington,
Ontario). Gels were pretreated with 0.2 N HCl for
10 min, denatured in 1.5 N NaCl/0.5 N NaOH for
45 min, and neutralized in 1.5 N NaCl/1 M Tris
pH7.4 for 30 min prior to capillary transfer onto a
positively charged nylon transfer membrane Hybond-
N
? (Amersham; Piscataway, NJ). Probes were radi-
olabeled with a
32P dCTP (Roche; Branchburg, NJ),
and included the following: a 605 bp probe from the
Myt1 50region of homology; a 791 bp probe from the
Transgenic Res (2011) 20:951–961 953
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probe (from pPNT, LDN 33). The Myt1 50 and 30
homology probes were cloned from 129/SvEv geno-
mic DNA using PfuUltra high ﬁdelity DNA poly-
merase (Stratagene; Garden Grove, CA) with the
following primers: For the 605 bp 50 homology
probe, the forward primer was 50GTTCCAAGA
CAGCTATTACATGGTGGC30, and reverse primer
was50GGAATTTGTATCTCTCCAGGGTCACTG30.
For the 791 bp 30 homology probe, the forward
primer was 50GACTGTGACTTACAAAGGGCTT
GCTG30, and the reverse primer was 50CTGACT
GATGGGTACCTCTCAATAGG30. Each PCR frag-
ment was subcloned into the pCR-Blunt II TOPO
vector (Invitrogen; Carlsbad, CA). The 605 bp 50
homology probe can be excised from the pCR-
50Myt1outSB605 plasmid with EcoRI, and the 791 bp
30 homology probe can be excised from the pCR-
30Myt1outSB791 plasmid with NotI and KpnI.
Hybridizations were carried out in Hybrisol I solution
(Millipore; Billerica, MA) with 100 lg/ml salmon
sperm DNA (Phoenix Bio Tech; Phoenix, AZ).
Northern analysis
RNA was prepared from E15 brains by homogeniza-
tion in TRIzol reagent (Invitrogen) using an IKA
Ultra-Turrax T8 power homogenizer, followed by
precipitation with isopropyl alcohol. RNA was elec-
trophoresed on 1% agarose gels containing ethidium
bromide together with a RNA Millenium molecular
weight marker (Ambion; Austin, TX), and blotted
with NorthernMax-Gly reagents (Ambion). Capillary
transfered onto positively charged nylon transfer
membrane Hybond-N
?(Amersham). Probes were
radiolabeled with a
32P dCTP (Roche; Branchburg,
NJ) and included the following: a 580 bp cDNA
probe, cloned from pmMyt1 plasmid containing
murine Myt1 cDNA using PfuUltra high ﬁdelity
DNA polymerase (Stratagene) with the forward
primer: 50 GAATTCGGAGCTCTCAATGGTT-
CATC 30, and the reverse primer: 50GAATTCCAG
CTTGCTTGATCGTTTCC 30. This 580 bp PCR
fragment was then subcloned into the pCR-Blunt II
TOPO vector (Invitrogen) to generate the pCR-
Myt1NB580 plasmid. The 580 bp Myt1 cDNA
fragment can be excised from the Myt1NB580
plasmid with EcoRI or directly labeled with a
32P
dCTP (Roche). Hybridizations were carried out in
Hybrisol I solution (Millipore) with 100 lg/ml
salmon sperm DNA (Phoenix Bio Tech).
Genotyping by PCR
Tail or toe lysates were prepared by incubating
samples from 3-16 h in 50 ll of 1 M Tris pH 8.0,
5 M NaCl, 0.5 M EDTA, 10% Tween 20, 10% NP-
40, 0.4 lg/ml freshly added proteinase K. Following
centrifugation to remove debris, 1 ll of DNA lysate
was added to 0.1 ll of each primer (0.4 ll total), 0.2
ll Taq DNA polymerase (Promega), 5 ll 1% Triton
X-100 and 18.4 llH 2O in EasyStart Micro 50 tubes
(MbP; San Diego, CA). Two primer pairs were used
in each tube in order to discriminate between
transgenic homozygous (Myt1
-/-), heterozygous
(Myt1
±), and wild-type mice (Myt1
?/?). To amplify
a 325 bp transgenic fragment, the forward primer was
50CAGCCATACCACATTTGAGAGG30 and the
reverse primer was 50TGCATTGGCACTGAATC
GATGG30. To amplify a 188 bp wild type fragment,
the forward primer was 50CCAACTTGCTTCTTT
TGGTCCC30 and the reverse primer was 50GGCT
CGCTTGTCATCACTTTC30. The PCR cycling was
carried out for a total of 30 cycles in a Hybaid, PCR
Express HBPX110 (Thermo; Essex, UK) under the
following conditions: melt at 94C for 5 min, dena-
ture at 94C for 30 s, anneal at 55C for 30 s, extend
72C for 1 min (30 cycles). PCR products were
analyzed on a 2% agarose gel containing ethidium
bromide. The marker lane consists of the 100 bp
DNA ladder Plus (Fermentas). In this assay, Myt1
-/-
mice display a single 325 bp band, Myt1
± display
both the 325 bp and 188 bp bands, and Myt1
?/? mice
display a single 188 bp band.
Immunohistochemistry and statistical analysis
E18 spinal cords were immersion ﬁxed in phosphate-
buffered 4% paraformaldehyde with picric acid (FD
Neurotechnologies; Baltimore, MD). Following cryo-
protection treatment in 0.1 M phosphate buffer (pH
7.4) containing 20% sucrose for 72 h at 4C, spinal
cords were rapidly frozen and stored at -75C. Serial
cryostat sections (20 lm) were cut transversely
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123through the whole spinal cord. Every 1st, 2nd and 3rd
section of each series of 10 sections were mounted on
Superfrost Plus microscope slides (3 sections per
slide). Upon drying, sections were stored at -20C.
Following washes in 0.01 M phosphate-buffered
saline (PBS; pH 7.4), sections were incubated
overnight at 4C in PBS containing 1% normal
donkey serum, 4% BSA (Jackson ImmunoResearch,
West Grove, PA), 0.3% Triton X-100 (Sigma, St.
Louis, MO), the polyclonal rabbit anti-eGFP IgG
(1:200, Invitrogen, Carlsbad, CA) and the biotinyla-
ted monoclonal mouse anti-NeuN antibody (1:100,
Millipore, Billerica, MA). This was followed by
incubation of sections at room temperature in the
PBS/Triton X solution containing Alexa Fluor
 488
donkey anti-rabbit IgG (Molecular Probe, Eugene,
OR) for 1 h, and then in the PBS/Triton X containing
streptavidin conjugated Alexa Fluor
 594 (Molecular
Probe) for another hour. Each step was followed by
washes in PBS. Sections were coverslipped using
Vectashield
 with DAPI (Vector Labs, Burlingame,
CA) and stored at 4C.
Photographs of ﬁxed 18-day mouse embryo spinal
cord sections were captured with the Olympus
1 9 70 ﬂuorescent microscope using the 4X
UPLanF1 objective lens. The photographs were
processed and digitized using the CoolSNAP fX
camera (Photometrics, Roper Scientiﬁcs, Tucson,
AZ) and the IP Lab version 3.9.5 rl program
(Scientiﬁc Image Processing, BDBiosciences, San
Jose, CA). The photographs were further processed
with Adobe Photoshop CS3, Version 10.0.1 (Adobe
Systems Inc., San Jose, CA) utilizing the Channel
window to prepare separate ﬂuorescent images for the
eGFP (Alexa Fluor
488), NeuN (Alexa Fluor
594)
and DAP.
Cells that ﬂuoresced for eGFP, NeuN and DAPI
were counted using the ImageJ program (Rasband,
W.S., ImageJ, National Institutes of Health,
Bethesda, MD, USA, http://rsb.info.nih.gov/ij/
1997–2009 (also see Abramoff et al. 2004). Two
separate sets of 18 day embryo spinal cords from the
wild type, heterozygote and homozygote animals
were counted. The cells in fourteen sections repre-
senting 14 different areas of each 18 day mouse
embryo spinal cord (wild type, heterozygote and
homozygote) from the cervical to sacral were coun-
ted. The 2 sets were averaged and graphed with
Microsoft Excel (Microsoft Corp., Redmond, WA).
Results
Generating Myt1 knock-in mice
Myt1 can be transcribed from two alternative
promoters to yield either a 6 zinc ﬁnger protein
(6ZFMyt1 or Myt1a) or a 7 zinc ﬁnger protein
(7ZFMyt1 or Myt1b; Matsushita et al. 2002; Nielsen
et al. 2004). 7ZFMyt1 is by far the predominant
product of the Myt1 locus in all tissues examined
(Matsushita et al. 2002), (Nielsen et al. 2004); (Gu
et al. 2004). To establish the in vivo role of Myt1, we
designed a knock-in construct so that the promoter for
the seven zinc ﬁnger Myt1 isoform (7ZFMyt1) would
drive expression of a green ﬂuorescent protein
(eGFP) reporter together with the cre recombinase
(Fig. 1). Cassettes for these two reporter genes were
fused in frame, so that translation of the eGFP-iCre
fusion protein would occur from the eGFP-iCre
initiation codon within exon 2. The initiation codon
for 7ZFMyt1 in exon 2 was altered. Also included
was a neo selectable marker ﬂanked with frt sites so
that the neo cassette, which can impact the expression
of the targeted gene, could be subsequently excised
by crossing transgenic mice with mice expressing the
ﬂip recombinase.
Correctly recombined transgenes were docu-
mented in two lines of Myt1 knock-in mice by
Southern analysis (Fig. 2). Using a probe that is distal
to the 50 region of homology (panel b), the expected
5.9 kb KpnI band (lanes 2 and 3) and 6.3 kb HindIII
band (lanes 5 and 6) were observed in both Myt1
±,
Neo
± and Myt1
-/-, Neo
-/- mice. Using a probe that
is distal to the 30 region of homology (panel a), the
expected 8.4 kb HindIII band was observed in
Myt1
±, Neo
± (lane 2) and Myt1
-/-, Neo
?/? (lane
3) animals. This band was also detectable with a neo
probe (lane 8). A smaller HindIII band of 7.2 kb was
observed in animals that were derived from matings
with mice expressing the ﬂip recombinase (lanes 4
and 5), indicating that neo had been excised from the
targeted Myt1 locus in these animals. The 50region of
homology probe and the 30region of homology probe
together conﬁrm the correct homologous recombina-
tion of the electroporated knock-in construct.
No message corresponding to Myt1 was detectable
by Northern analysis in homozygous Myt1 knock-in
mice at embryonic day 15, a time when Myt1 is
normally highly expressed (lanes 3 and 6, Fig. 3).
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123Fig. 1 Construction of Myt1 knock-in Mice. The targeting
vector is designed to eliminate exon 2, which contains the
initiation codon for 7ZFMyt1, (depicted as AUG with a red
arrow) and drive expression of the eGFP/cre fusion gene
directly from the 7ZFMyt1 promoter. The probes used on
Southern blots to document the recombinant event are shown
in pink and are distal to the 50region of homology (in red) and
the 30region of homology (in light blue). The frt recombination
sites ﬂanking the Neomycin (Neo) are marked with triangles.
Note that following excision of the neomycin cassette by
breeding with mice expressing the ﬂip recombinase, a single frt
site remains, together with a loxP site. The 22 exons are
pictured as boxes (not drawn to scale). (Color ﬁgure online)
Fig. 2 Southern Analysis of Myt1 knock-in Mice. In panel a,
Hind III-digested genomic DNA was hybridized with either the
30 Myt1 outside region of homology probe (lanes 1–5) or the
neo probe (lanes 7–9). lane 1 wild type DNA: Myt1
?/?,
Neo
-/-; lane 2 Myt1
±, Neo
±; lane 3 Myt1
-/-, Neo
?/?; lane 4
Myt1
±, Neo
-/-; lane 5 Myt1
-/-, Neo
-/-; lane 6 no DNA; lane
7 Myt1
?/?, Neo
-/-; lane 8 Myt1
-/-, Neo
?/?; lane 9 Myt1
-/-,
Neo
-/-. The 30 Myt1 probe identiﬁes a 12.2 kb HindIII band in
wild type mice and an 8.4 kb HindIII band in transgenics,
which also displays hybridization to the neo probe. In
transgenics lacking Neo (lanes 4 and 5), the 30 Myt1 probe
identiﬁes a 7.2 kb HindIII band. In panel b, KpnI (lanes 1–3)
or HindIII-digested (lanes 4–6) genomic DNA was hybridized
with the 50Myt1 outside region of homology probe. lane 1
Myt1
?/?, Neo
-/-; lane 2 Myt1
±, Neo
±; lane 3 Myt1
-/-,
Neo
?/?; lane 4 Myt1
?/?, Neo
-/-; lane 5 Myt1
±, Neo
±; lane 6
Myt1
-/-, Neo
?/?. The 50 Myt1 probe identiﬁes a 8.7 kb KpnI
band in wild type mice and a 5.9 kb KpnI band in transgenics.
It also reveals a 12.2 kb HindIII band in wild type mice and a
6.3 kb HindIII band in transgenics. Both panels include a 1 kb
DNA ladder Plus as a molecular weight marker
956 Transgenic Res (2011) 20:951–961
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as much of the 5.1 kb Myt1 transcripts at E15 when
either total RNA (lane 2) or polyA-selected RNA
(lane 5) was analyzed.
Phenotype of Myt1 knock-in mice
In our initial PCR genotyping and Southern blot
analysis of transgenic animals, no homozygous
animals were present in litters analyzed at postnatal
day 7. To determine if there was a viability problem
with homozygous animals, and to pinpoint the time at
which survival may be affected, we set up a series of
matings between heterozygous animals. After col-
lecting embryos throughout prenatal development,
we determined that homozygous animals survived
through the prenatal period but died shortly after
birth. Table 1 summarizes the results from an
embryonic and a postnatal time point. At embryonic
day 18, the observed numbers of wild type, homo-
zygous and heterozygous closely approximate the
expected Mendelian ratio, with 26.8% of the off-
spring representing homozygous animals. No living
homozygous animals were found from the 15 matings
analyzed at birth or the 18 matings that were analyzed
at later postnatal ages. One mutant allele had no
affect on viability.
To determine the cause of death, heterozygous
animals were mated and a Caesarean section per-
formed shortly before the scheduled birth. Pups were
kept at 37C during the hour observation period.
Unlike wild type or heterozygous animals, the
homozygous animals all died within 20 min. Homo-
zygous animals never progressed from gasping to
normal breathing. Their lungs did not appear white in
color and were not inﬂated as evidenced by their lack
of buoyancy when placed in a container of phosphate
buffered saline.
Heterozygous animals appeared undistinguishable
from wild type animals and reproduced normally.
Neural cells with an active Myt1 promoter
can be tracked with eGFP in knock-in mice
Myt1 expressing cells in null or heterozygous
embryos can be identiﬁed through the eGFP marker
(Fig. 4). At E18, eGFP cells are distributed through-
out the spinal cord (panels c). These eGFP cells were
not double labeled with Neuronal Nuclei protein
(NeuN; panels a), suggesting that Myt1 neural
progenitors have not differentiated into the mature
neurons identiﬁed by NeuN staining at this age.
Moreover, the pattern of NeuN staining in transgenic
embryos was similar to that in wild type embryos
(panels b). The lack of overlap between eGFP-
positive cells and NeuN cells is shown in a higher
Fig. 3 Northern Analysis of the Myt1 knock-in Mice. This
analysis was carried out after the crossing with B6;SJL-
Tg(ACTFLPe)9205Dym/J mice that express the Saccharomy-
ces cerevisiae FLP1 recombinase gene. All mice were
genotyped to verify that the neo gene was absent. In panel a,
a Myt1 cDNA probe identiﬁed a 5.1 kb band in either total
RNA (lanes 1–3) or mRNA (lanes 4–6) in mice containing at
least one wild-type Myt1 allele. lane 1 Myt1
?/?, lane 2 Myt1
±,
lane 3 Myt1
-/-, RNA Millenium molecular weight marker;
lane 4 Myt1
?/?, lane 5 Myt1
±, lane 6 Myt1
-/-. No Myt1
transcripts in any size range are detectable in the null mice. In
panel b, the ethidium bromide stained gel shows the integrity
of the RNA samples
Transgenic Res (2011) 20:951–961 957
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(Fig. 5). Quantitation of the immunohistochemistry is
shown in Fig. 6. No signiﬁcant difference in the
number of NeuN cells was apparent in null or
heterozygous animals compared to wild type. Like-
wise, there was no signiﬁcant different in the number
of eGFP cells in heterozygous or null animals.
Discussion
The Myt1 knock-in mice should provide an invalu-
able resource for: (1) deﬁning the role of the Myt1
gene family in the speciﬁcation of neural lineages and
the development of oligodendrocytes, and (2) deter-
mining the set of gene targets that this structurally
Fig. 4 Immunohistochemistry of Spinal Cord Sections from
Myt1 knock-in Mice. Spinal cord sections from E18 wild type
mice (?/?), heterozygotes (±) or null mice (-/-) were triple
stained with: panel a, eGFP (green), NeuN (red) and DAPI.
panel b shows NeuN alone; panel c shows eGFP alone; and
panel d shows DAPI alone. The size bar = 10 microns. (Color
ﬁgure online)
Table 1 Genotyping the progeny from Myt1 ± Matings
E18 embryos (from 48 matings) Postnatal day 7 mice (from 18 matings)
Genotype Myt1?/? Myt1± Myt1-/- Myt1?/? Myt1± Myt1-/-
Number of offspring 102 190 107 37 52 0
% of offspring 25.6 47.6 26.8 41.6 58.4 0
958 Transgenic Res (2011) 20:951–961
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to in vivo. Recently, attention to the Myt1 gene
family has focused on the discovery that the Myt1
paralog, Myt1l, is one of a simple trio of genes
necessary for the efﬁcient conversion of mouse
ﬁbroblasts into functional neurons in vitro (Vierbu-
chen et al. 2010). While documenting that a Myt1
gene family member is instrumental in neural spec-
iﬁcation, this advance is short on the molecular
details of what genes are activated or repressed and in
what stages of the cells. In the Myt1 knock-in mice,
lineage tracing is possible due to the incorporation of
a cre coding region fused in frame to the GFP
reporter. Heterozygous transgenic animals mated to
the ROSA26 Cre indicator strain (Soriano 1999) will
display b-galactosidase expression in all Myt1 line-
age cells. Additional Cre-reporter strains that would
be helpful include the Z/AP line that contains a
human placental alkaline phosphatase (hPLAP)
reporter (Lobe et al. 1999) and the R26R-EYFP line
with an enhanced yellow ﬂuorescent protein (EYFP)
reporter (Srinivas et al. 2001).
Elimination of Myt1 expression disrupts neural
development. Another Myt1 transgenic model con-
structed by Gu and colleagues displayed a breathing
defect attributable to improper innervation of the
diaphragm in the transgenic mice (Wang et al. 2007).
Likewise, the homozygous knock-in Myt1 mice in
the present study presented with breathing difﬁculties
shortly after birth. Given that the transgenic line
constructed by Gu and colleagues is potentially a
dominant negative model, since altered Myt1 tran-
scripts are present (Wang et al. 2007), it is reassuring
that this phenotype is seen in both transgenic models.
The new data provided in the present study includes
the observation that eliminating Myt1 does not affect
the number or distribution of neurons. These data
would not have been predicted based on earlier
observations that Myt1 is expressed by rat cortical
neuronal progenitors at E11 and is up-regulated 2.7-
fold between E11 and E13 (Nielsen et al. 2009). In
the Myt1 eGFP/cre knock-in mice, the distribution
and number of differentiated neurons in the spinal
cord appears normal, as does the pattern of neural
Fig. 5 Immunohistochemistry of Spinal Cord Sections from
Myt1 knock-in Mice. A spinal cord section from anE18
homozygote (-/-) mouse was triple stained with eGFP
(green), NeuN (red) and DAPI. The size bar = 10 microns.
(Color ﬁgure online)
Fig. 6 Quantitation of Immunohistochemistry. The average of
the total number of cells labeled with NeuN, eGFP or DAPI per
E18 spinal cord section are shown for wild type mice (?/?;
blue bars), heterozygotes (±; red bars) or null mice (-/-;
yellow bars). Black lines represent standard deviations. (Color
ﬁgure online)
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123cells in which the Myt1 promoter actively drives the
expression of the eGFP reporter (Figs. 4, 5 and 6). Of
note, the eGFP reporter is not expressed by the
neuronal population labeled by NeuN in the spinal
cord. Oligodendrocytes and motor neurons were
thought to derive from a common precursor express-
ing Olig 1 and Olig 2 (Zhou and Anderson 2002;L u
et al. 2000), but subsequent fate mapping studies
identiﬁed multiple sources generating oligodendro-
cytes in the brain and spinal cord (Kessaris et al.
2006; Cai et al. 2005). Further lineage tracing studies
with the cre reporter may help resolve the origin of
some of these oligodendrocyte subpopulations.
Myt1 is also critical for islet cell differentiation, as
shown in a series of elegant experiments by Gu and
Hecksher-Sorensen and their colleagues (Ahnfelt-
Ronne et al. 2007; Wang et al. 2007, 2008). The loss-
of-function Myt1 model constructed by targeting
exon 9 has a Myt1 mRNA level reduced by over
fourfold; heterozygous mice displayed normal pan-
creatic development, making it unlikely that the
Myt1- allele behaves in a dominant negative fashion
in this transgenic model (Wang et al. 2007). Com-
pensatory activation of the paralogs Myt1l and Myt3
occurs in the embryonic Myt1
-/- pancreas. Of
particular interest is the observation that Myt1 and
neurogenin 3 (Ngn3) positively regulate each other’s
expression in the developing pancreas, with Notch
mediated signaling regulating the number of Ngn3?
cells. A Notch signaling pathway is likewise a feature
of the switch from neurogenesis to gliogenesis in the
spinal cord, which involves not only the induction of
Olig2 expression, but also the down-regulation of
neurogenin 1 (Ngn1) and neurogenin 2 (Ngn2) via
Notch signaling (Zhou et al. 2001).
Genomic approaches to oligodendrocyte biology
have greatly expanded our horizon by showing the
multiple different temporal transcription factor
expression patterns occurring during oligodendrocyte
differentiation. (Dugas et al. 2006; Nielsen et al.
2006). While Myt1 is down-regulated during oligo-
dendrocyte differentiation, Myt is in the company of
sixty other transcription factors that are up-regulated
over twofold in cortical neuronal progenitors between
embryonic day 11 and 13 (Nielsen et al. 2009).
Seventypercentofthetranscriptionfactorsup-regulated
in cultured oligodendrocytes during differentiaton in
the absence of neurons are also up-regulated in
acutely isolated developing oligodendrocytes (Dugas
et al. 2006; Nielsen et al. 2006). Many of these
transcription factors await functional studies before
their node in the complex network regulating oligo-
dendrocyte development can be assigned. In Myt1
knock-inmice,theabsenceofMyt1isexpectedtolead
to the inactivation of an array of target genes.
Transgenic mice provide a handle for identifying
target genes of transcription factors when combined
with the powerful ‘‘omics’’ technologies to identify
which transcripts are over or under-expressed in the
presence or absence of a given transcription factor.
Given the wealth of molecular detail available on how
Myt1 burrows into the DNA groove and recruits
histonedeacetylasetoregulateneuraltranscription,the
Myt1knock-inmiceofferaninvaluabletoolforfurther
exploration of the transcriptional circuitry in neural
cells.
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